Table 5.
Patient No. | Age | Sex | Location of primary | Pathology | Location of metastatic disease | No. of months after 3year scans until symptoms | Additional therapy | No. of months after recurrence until death |
---|---|---|---|---|---|---|---|---|
1 | 50 | F | Lower extremity | 1.9 mm, 3 mit/mm2, CL IV, NU, Stage IIIA | Retroperitoneal, inguinal, pelvic LN | 0.25 | HD IL-2 Dacarbazine | 6.5 |
2 | 70 | F | Head and neck | 1.33 mm, 15 mit/mm2, CL IV, NU, Stage IIIB | Lung, hemidiaphragm | 0 | None | 1 |
Mit=mitoses, CL=Clark level, NU=non-ulcerated, LN=lymph nodes